Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist.  The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am.   Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases.  SAM has strategic collaborations with public and private institutions for research and clinical work.  SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi

China Kunda Technology Holdings Limited

It has been a bleak month for IPOs worldwide, not just in Singapore. Basically, the underwriters will not launch any IPOs unless the Company, IPO consultants and pre-IPO investors can find their own 'anchor placees'. One of my pre-ipo investment was still "stuck" in the MAS Opera as the anchor was unable to 'furnish the cheque' needed.

China Kunda is offering 95.284m shares of which 67.2m are new shares and the rest are vendor shares. China Kunda is a provider of precision moulds, plastic injection parts, in-mould decoration products to the electronics, electrical, automobile and specialised devices industries. The market cap post-listing is S$68.8 million. IPO will close on 7 Oct at 12pm.

Unaudited 9 months sales for 2008 is HK$76.55m and profit after tax HK$39.448m. Assuming the sales are evenly spread out, the full year profit will be HK$102m and net profit will be HK$52.6m and based on 320m shares, the EPS will be 16.44 HK cents (or about Singapore 3.04 cents). Based on the IPO price of 21.5 cents, it is valued at 7x PE. Frankly, under such economic climate, i cant foresee the company to do better in 2009 than in 2008, perhaps that is one reason why it has to list NOW intead of postponing the IPO.

Pre-IPO investors are getting a 50% discount and most likely they are also helping to ensure the IPO is "launched" successfully. It is also very rare to see such a young CFO being appointed as executive director of the Company as well.

My view is that the IPO is fully valued with some many S-chips trading at 3-5x PE currently, it makes no sense to invest in this Company based on the IPO price. Investors should be able to get in at cheaper prices post listing. Avoid.

Comments